Increased expression of E3 ubiquitin ligases targeting p53 in CLL patients with wild-type TP53 exhibits associations with clinical features of the disease
- 16 November 2015
- journal article
- letter
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 57 (6) , 1471-1473
Abstract
Increased expression of E3 ubiquitin ligases targeting p53 in CLL patients with wild-type TP53 exhibits associations with clinical features of the disease.. . . doi: 10.3109/10428194.2015.1096355Keywords
This publication has 13 references indexed in Scilit:
- Pirh2Cell Cycle, 2013
- A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53Science Signaling, 2013
- COP1 is a tumour suppressor that causes degradation of ETS transcription factorsNature, 2011
- Posttranslational Modification of p53: Cooperative Integrators of FunctionCold Spring Harbor Perspectives in Biology, 2009
- Blinded by the Light: The Growing Complexity of p53Cell, 2009
- The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target GenesMolecular and Cellular Biology, 2006
- Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 DegradationCell, 2003
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Mdm2 promotes the rapid degradation of p53Nature, 1997